Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Corcept Therapeutics Inc’s stock clocked out at $70.84, up 0.35% from its previous closing price of $70.59. In other words, the price has increased by $0.35 from its previous closing price. On the day, 1.3 million shares were traded. CORT stock price reached its highest trading level at $71.665 during the session, while it also had its lowest trading level at $68.855.
Ratios:
To gain a deeper understanding of CORT’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 23.27 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 42.40. For the most recent quarter (mrq), Quick Ratio is recorded 2.96 and its Current Ratio is at 3.07. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Truist on November 06, 2023, Upgraded its rating to Buy and sets its target price to $38 from $29 previously.
On April 11, 2023, SVB Securities started tracking the stock assigning a Market Perform rating and target price of $25.
On April 04, 2023, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $27.Piper Sandler initiated its Overweight rating on April 04, 2023, with a $27 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 12 ’25 when Swisher Daniel N JR sold 2,200 shares for $72.06 per share. The transaction valued at 158,526 led to the insider holds 0 shares of the business.
Swisher Daniel N JR bought 400 shares of CORT for $28,620 on May 12 ’25. On May 12 ’25, another insider, Swisher Daniel N JR, who serves as the Director of the company, bought 1,800 shares for $72.17 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORT now has a Market Capitalization of 7512227328 and an Enterprise Value of 7196278272. As of this moment, Corcept’s Price-to-Earnings (P/E) ratio for their current fiscal year is 61.49, and their Forward P/E ratio for the next fiscal year is 26.63. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.89. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.96 while its Price-to-Book (P/B) ratio in mrq is 10.99. Its current Enterprise Value per Revenue stands at 10.499 whereas that against EBITDA is 64.641.
Stock Price History:
The Beta on a monthly basis for CORT is 0.15, which has changed by 1.5722585 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, CORT has reached a high of $117.33, while it has fallen to a 52-week low of $26.87. The 50-Day Moving Average of the stock is 5.71%, while the 200-Day Moving Average is calculated to be 30.21%.
Shares Statistics:
It appears that CORT traded 1.67M shares on average per day over the past three months and 1341760 shares per day over the past ten days. A total of 105.98M shares are outstanding, with a floating share count of 93.74M. Insiders hold about 11.60% of the company’s shares, while institutions hold 79.50% stake in the company. Shares short for CORT as of 1745971200 were 13183760 with a Short Ratio of 7.90, compared to 1743379200 on 16526709. Therefore, it implies a Short% of Shares Outstanding of 13183760 and a Short% of Float of 16.76.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
